High Outlier
Strength
250 mg/1
Manufacturer
INA Pharmaceutics IncNDC
74157000960
Classification
Brand (ANDA)
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
DIFLUNISALApproval Type
Generic (ANDA)
FDA Application
ANDA202845On Market Since
8/19/2024
Pharmacological Classes
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.